Molecular basis of quinolone resistance in Escherichia coli from wild birds

Canadian Journal of Veterinary Research

Volumn 68, Issue 3, 2004, Pages 229-231

  Jiménez Gómez, Pedro A ^a   Garcia de los Rios J E ^a   Rojas Mendoza, A ^b   de Pedro Ramonet, P ^a   Garcia Albiach R ^a   Reche Sainz, M P ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEROBACTIN; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; LEUCINE; NALIDIXIC ACID; NUCLEOTIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SERINE;

ANIMAL DISEASE; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BIRD; CODON; ENTEROBACTER INFECTION; ESCHERICHIA COLI; GENE MUTATION; GENE SEQUENCE; GRAM NEGATIVE SEPSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; SEQUENCE ANALYSIS;

ANIMALS; ANIMALS, WILD; ANTI-INFECTIVE AGENTS; BIRD DISEASES; BIRDS; DNA PRIMERS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FLUOROQUINOLONES; GENES, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MUTATION; POLYMERASE CHAIN REACTION; SEPSIS;

ANIMALIA; AVES; BACTERIA (MICROORGANISMS); ENTEROBACTER; ESCHERICHIA COLI; NEGIBACTERIA;

EID: 4444314045     PISSN: 08309000     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Dho-Moulin M, Fairbrother JM. Avian pathogenic Escherichia coli (APEC). Vet Res 1999;30:299-316.
2. Bailey TA, Silvanose C, Wernery U, Samour JH, Naldo J. Antimicrobial resistance and minimum inhibitory concentrations of bacteria isolated from bustards in the United Arab Emirates. Avian Dis 1998;42:690-697.
3. Everett MJ, Jin YF, Ricci V, Piddock LJ. Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli isolates isolated from humans and animals. Antimicrob Agents Chemother 1996;40:2380-2386.
4. Yamamoto S, Terai A, Yuri K, Takeda Y, Yoshida O. Detection of urovirulence factors in Escherichia coli by multiplex polymerase chain reaction. FEMS Immunol Med Microbiol 1995;12:85-90.
5. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. 5th edition. Approved standard M2-A6. National Committee for Clinical Laboratory Standards, Wayne, Pennsylvania, USA. 1999.
6. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th edition. Approved standard M31-A. National Committee for Clinical Laboratory Standards, Wayne, Pennsylvania, USA. 1999.
7. Vila J, Ruiz J, Marco F, et al. Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs. Antimicrob Agents Chemother 1994;38: 2477-2479.
8. Vila J, Ruiz J, Goñi P, De Anta MT. Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother 1996;40:491-493.
9. Ruiz J, Casellas S, Jimenez de Anta MT, Vila J. The region of the parE gene, homologous to the quinolone-resistant determining region of the gyrB gene, is not linked with the acquisition of quinolone resistance in Escherichia coli clinical isolates. J Antimicrob Chermother 1997;39:839-840.
10. Allan BJ, Van den Hurk JV, Potter AA. Characterization of Escherichia coli isolated from cases of avian colibacillosis. Can J Vet Res 1993;57:146-151.
11. White DG, Piddock LJ, Maurer JJ, Zhao S, Ricci V, Thayer SG. Characterization of fluoroquinolone resistance among veterinary isolates of avian Escherichia coli. Antimicrob Agents Chemother 2000;44:2897-2899.